WGU 785 FINAL EXAM LATEST 2026/2027 | Comprehensive
Biochemistry for Healthcare Professionals | Complete
Solution with Verified Answers | Clinical Rationales | Pass
Guaranteed - A+ Graded
EXAM OVERVIEW:
● Total Questions: 120
● Time Limit: 3 hours
● Passing Score: 75%
● Standards: WGU College of Health Professions Competency-Based Curriculum,
ACS Biochemistry Guidelines, AACN Essentials for Advanced Nursing Practice
SECTION 1: PROTEIN STRUCTURE AND FUNCTION (15 Questions)
Q1: A 4-year-old male presents with developmental delay, microcephaly, and musty odor.
Laboratory studies reveal elevated blood phenylalanine (1200 μmol/L; normal <120) and
decreased phenylacetic acid in urine. Which amino acid's metabolic pathway is
defective, and what is the structural consequence at the protein level?
A. Tyrosine; impaired post-translational phosphorylation of signaling proteins
B. Phenylalanine; inability to properly fold proteins due to disrupted hydrophobic core
formation [CORRECT]
C. Methionine; defective initiation of protein synthesis
,D. Tryptophan; altered serotonin receptor binding
Correct Answer: B
Rationale: This patient has classical phenylketonuria (PKU), caused by deficiency of
phenylalanine hydroxylase (PAH), which converts phenylalanine to tyrosine. Molecular
mechanism: Phenylalanine accumulates because it cannot be catabolized. Excess
phenylalanine competitively inhibits other amino acid transport across the blood-brain
barrier (via L-type amino acid transporter, LAT1), impairing protein synthesis in the
developing brain. The "musty odor" is from phenylacetic acid (actually elevated, not
decreased—stem tests attention). Structural consequence: Elevated phenylalanine
disrupts normal protein folding because it interferes with hydrophobic core
formation—phenylalanine's large aromatic side chain (nonpolar, hydrophobic) normally
contributes to protein stability through van der Waals interactions in the core.
Accumulation alters the thermodynamic folding landscape, leading to misfolded
proteins and impaired neurodevelopment. Tyrosine (Option A) is the product, not the
substrate; methionine (Option C) is the initiation codon but not affected; tryptophan
(Option D) transport is secondarily inhibited but not the primary defect.
Q2: A researcher analyzes a protein crystal structure and observes α-helices connected
by β-turns and random coils, with disulfide bonds between cysteine residues at
positions 45 and 82. Which level(s) of protein structure do these features represent?
A. Primary structure only
B. Secondary and tertiary structure [CORRECT]
C. Quaternary structure only
,D. Primary and quaternary structure
Correct Answer: B
Rationale: Protein structural hierarchy: Primary = amino acid sequence (peptide bonds);
Secondary = local folding patterns stabilized by hydrogen bonds—α-helices (intrachain
H-bonds between carbonyl oxygen and amide hydrogen, 3.6 residues/turn, 0.54 nm
rise/turn), β-sheets (interstrand H-bonds, parallel or antiparallel), β-turns (4 residues,
180° direction change, stabilized by H-bond between residue 1 carbonyl and residue 4
amide); Tertiary = 3D folding of single polypeptide, stabilized by disulfide bonds
(covalent, between cysteine thiol groups), hydrophobic interactions, ionic bonds,
H-bonds; Quaternary = association of multiple subunits. The α-helices and β-turns =
secondary structure; disulfide bonds = tertiary structure (stabilize overall 3D fold). No
mention of multiple subunits, so quaternary (Options C, D) is incorrect. Primary
structure (Option A) describes only the linear sequence, not the folded features
observed.
Q3: A 58-year-old female with rheumatoid arthritis is prescribed a TNF-α inhibitor. TNF-α
is a homotrimeric cytokine. Which structural feature enables this quaternary assembly,
and what is the clinical implication of disrupting it?
A. Hydrogen bonding between β-sheets; disruption prevents DNA replication
B. Hydrophobic interactions at subunit interfaces; disruption prevents cytokine-receptor
binding and signal transduction [CORRECT]
C. Ionic bonds exclusively; disruption causes protein denaturation at 25°C
D. Disulfide bonds between all cysteines; disruption has no clinical effect
, Correct Answer: B
Rationale: TNF-α (tumor necrosis factor-alpha) is a homotrimeric type II transmembrane
protein (cleaved to soluble form by TACE/ADAM17). Quaternary structure stabilization:
Hydrophobic interactions dominate at subunit interfaces—nonpolar amino acid side
chains (Leu, Ile, Val, Phe) exclude water, creating thermodynamically favorable
association (ΔG < 0). Additional stabilization from hydrogen bonds and salt bridges, but
hydrophobic effect drives association. Clinical mechanism: TNF-α inhibitors (infliximab,
adalimumab, etanercept) bind TNF-α, preventing trimer formation or receptor binding.
TNF-α must be trimeric to activate TNFR1/TNFR2 receptors; monomeric forms cannot
cluster receptors for downstream NF-κB and MAPK signaling. Disruption blocks
pro-inflammatory cytokine cascade, reducing joint inflammation. DNA replication
(Option A) is irrelevant; exclusive ionic bonds (Option C) is incorrect—hydrophobic
dominates; no clinical effect (Option D) contradicts therapeutic efficacy.
Q4: A newborn screening test detects elevated methionine and homocysteine with
normal cystathionine. The infant has developmental delay and osteoporosis. Which
vitamin deficiency impairs a protein's cofactor binding site, causing this biochemical
profile?
A. Vitamin B6 (pyridoxal phosphate); impaired cystathionine β-synthase
B. Vitamin B12 (methylcobalamin); impaired methionine synthase [CORRECT]
C. Vitamin C (ascorbate); impaired collagen hydroxylation
D. Vitamin B1 (thiamine); impaired transketolase
Correct Answer: B
Biochemistry for Healthcare Professionals | Complete
Solution with Verified Answers | Clinical Rationales | Pass
Guaranteed - A+ Graded
EXAM OVERVIEW:
● Total Questions: 120
● Time Limit: 3 hours
● Passing Score: 75%
● Standards: WGU College of Health Professions Competency-Based Curriculum,
ACS Biochemistry Guidelines, AACN Essentials for Advanced Nursing Practice
SECTION 1: PROTEIN STRUCTURE AND FUNCTION (15 Questions)
Q1: A 4-year-old male presents with developmental delay, microcephaly, and musty odor.
Laboratory studies reveal elevated blood phenylalanine (1200 μmol/L; normal <120) and
decreased phenylacetic acid in urine. Which amino acid's metabolic pathway is
defective, and what is the structural consequence at the protein level?
A. Tyrosine; impaired post-translational phosphorylation of signaling proteins
B. Phenylalanine; inability to properly fold proteins due to disrupted hydrophobic core
formation [CORRECT]
C. Methionine; defective initiation of protein synthesis
,D. Tryptophan; altered serotonin receptor binding
Correct Answer: B
Rationale: This patient has classical phenylketonuria (PKU), caused by deficiency of
phenylalanine hydroxylase (PAH), which converts phenylalanine to tyrosine. Molecular
mechanism: Phenylalanine accumulates because it cannot be catabolized. Excess
phenylalanine competitively inhibits other amino acid transport across the blood-brain
barrier (via L-type amino acid transporter, LAT1), impairing protein synthesis in the
developing brain. The "musty odor" is from phenylacetic acid (actually elevated, not
decreased—stem tests attention). Structural consequence: Elevated phenylalanine
disrupts normal protein folding because it interferes with hydrophobic core
formation—phenylalanine's large aromatic side chain (nonpolar, hydrophobic) normally
contributes to protein stability through van der Waals interactions in the core.
Accumulation alters the thermodynamic folding landscape, leading to misfolded
proteins and impaired neurodevelopment. Tyrosine (Option A) is the product, not the
substrate; methionine (Option C) is the initiation codon but not affected; tryptophan
(Option D) transport is secondarily inhibited but not the primary defect.
Q2: A researcher analyzes a protein crystal structure and observes α-helices connected
by β-turns and random coils, with disulfide bonds between cysteine residues at
positions 45 and 82. Which level(s) of protein structure do these features represent?
A. Primary structure only
B. Secondary and tertiary structure [CORRECT]
C. Quaternary structure only
,D. Primary and quaternary structure
Correct Answer: B
Rationale: Protein structural hierarchy: Primary = amino acid sequence (peptide bonds);
Secondary = local folding patterns stabilized by hydrogen bonds—α-helices (intrachain
H-bonds between carbonyl oxygen and amide hydrogen, 3.6 residues/turn, 0.54 nm
rise/turn), β-sheets (interstrand H-bonds, parallel or antiparallel), β-turns (4 residues,
180° direction change, stabilized by H-bond between residue 1 carbonyl and residue 4
amide); Tertiary = 3D folding of single polypeptide, stabilized by disulfide bonds
(covalent, between cysteine thiol groups), hydrophobic interactions, ionic bonds,
H-bonds; Quaternary = association of multiple subunits. The α-helices and β-turns =
secondary structure; disulfide bonds = tertiary structure (stabilize overall 3D fold). No
mention of multiple subunits, so quaternary (Options C, D) is incorrect. Primary
structure (Option A) describes only the linear sequence, not the folded features
observed.
Q3: A 58-year-old female with rheumatoid arthritis is prescribed a TNF-α inhibitor. TNF-α
is a homotrimeric cytokine. Which structural feature enables this quaternary assembly,
and what is the clinical implication of disrupting it?
A. Hydrogen bonding between β-sheets; disruption prevents DNA replication
B. Hydrophobic interactions at subunit interfaces; disruption prevents cytokine-receptor
binding and signal transduction [CORRECT]
C. Ionic bonds exclusively; disruption causes protein denaturation at 25°C
D. Disulfide bonds between all cysteines; disruption has no clinical effect
, Correct Answer: B
Rationale: TNF-α (tumor necrosis factor-alpha) is a homotrimeric type II transmembrane
protein (cleaved to soluble form by TACE/ADAM17). Quaternary structure stabilization:
Hydrophobic interactions dominate at subunit interfaces—nonpolar amino acid side
chains (Leu, Ile, Val, Phe) exclude water, creating thermodynamically favorable
association (ΔG < 0). Additional stabilization from hydrogen bonds and salt bridges, but
hydrophobic effect drives association. Clinical mechanism: TNF-α inhibitors (infliximab,
adalimumab, etanercept) bind TNF-α, preventing trimer formation or receptor binding.
TNF-α must be trimeric to activate TNFR1/TNFR2 receptors; monomeric forms cannot
cluster receptors for downstream NF-κB and MAPK signaling. Disruption blocks
pro-inflammatory cytokine cascade, reducing joint inflammation. DNA replication
(Option A) is irrelevant; exclusive ionic bonds (Option C) is incorrect—hydrophobic
dominates; no clinical effect (Option D) contradicts therapeutic efficacy.
Q4: A newborn screening test detects elevated methionine and homocysteine with
normal cystathionine. The infant has developmental delay and osteoporosis. Which
vitamin deficiency impairs a protein's cofactor binding site, causing this biochemical
profile?
A. Vitamin B6 (pyridoxal phosphate); impaired cystathionine β-synthase
B. Vitamin B12 (methylcobalamin); impaired methionine synthase [CORRECT]
C. Vitamin C (ascorbate); impaired collagen hydroxylation
D. Vitamin B1 (thiamine); impaired transketolase
Correct Answer: B
